Please assess the completion status of the following clinical trial:

Trial Title: Filgrastim for the Promotion of Collateral Growth in Patients With CAD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years old~* 1- to 3-vessel coronary artery disease (CAD)~* Stable angina pectoris~* At least 1 stenotic lesion suitable for PCI~* No Q-wave myocardial infarction in the area undergoing CFI measurement~* Written informed consent to participate in the study~Exclusion Criteria:~* Patients admitted as emergencies~* Acute myocardial infarction~* Unstable CAD~* CAD treated best by CABG~* Patients with overt neoplastic disease~* Patients with diabetic retinopathy~* Liver or kidney disease~* Pre-menopausal women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).